Skip to main content
International Journal of Ophthalmology logoLink to International Journal of Ophthalmology
. 2022 Jun 18;15(6):1011–1014. doi: 10.18240/ijo.2022.06.21

Timely vitrectomy without intraocular lens removal for acute endophthalmitis after cataract surgery

Hai-Xia Guo 1, Ruo-Tian Xie 1,2, Yun Wang 1,3, Cai-Yun You 1, Yuan-Yuan Liu 1, Xiang-Da Meng 1, Jin-Guo Yu 1, Hua Yan 1,2
PMCID: PMC9203473  PMID: 35814892

Abstract

AIM

To investigate the clinical features, causative organisms and effects of timely vitrectomy and silicone oil tamponade without intraocular lens (IOL) removal in the treatment of acute-onset endophthalmitis after cataract surgery (APCE).

METHODS

We retrospectively analyzed the clinical features and microbiological factors in 10 eyes of 10 patients with APCE at Tianjin Medical University General Hospital from January 2010 to December 2018. Data on the clinical features, causative organisms, visual acuity, intraocular pressure (IOP) and complications were collected. The mean follow-up period was 25.5mo.

RESULTS

The mean age of the patients was 71.4y. The mean time between cataract surgery and the onset of endophthalmitis was 2.0d. Preoperative visual acuity ranged from no light perception to hand motion. After vitrectomy, the visual acuity increased in nine eyes (90%), and was unchanged in one eye (10%). A significant difference was observed between the mean preoperative (36.3±7.1 mm Hg) and postoperative IOP (14.9±4.3 mm Hg, P<0.05). Staphylococcus epidermidis was isolated in 5 eyes, S. aureus in 2 eyes, and Enterococcus in 1 eye. Postoperative complications mainly included fibrin exudates in the anterior chamber at the early stages in all eyes and temporary IOP elevation in one eye. No retinal detachment or ocular atrophy was observed during the follow-up period.

CONCLUSION

Under systemic antibiotic treatment and timely diagnosis, vitrectomy and silicone oil tamponade without IOL removal is a safe and effective method for APCE.

Keywords: vitrectomy, silicone oil, endophthalmitis, cataract, intraocular lens

INTRODUCTION

Although postoperative endophthalmitis is rare with an incidence of 0.02%-0.33%[1], it is one of the most serious complications after cataract surgery[2]. If this condition is not treated in a timely manner, it may result in visual loss and even ocular atrophy. The incidence of endophthalmitis following phacoemulsification and intraocular lens (IOL) implantation is estimated to be between 0.012% and 1.3% since 2000[3], and acute-onset post-cataract endophthalmitis (APCE) occurred in 0.04% cataract surgeries performed in the United States between 2013 and 2017[4]. Risk factors include anterior vitrectomy, cataract surgery combined with other ophthalmic surgery, younger age, intraoperative posterior capsule rupture, non-use of antibiotics, and non-use of behind-the-lens washout[5][6].

Previous treatment methods included vitrectomy, IOL removal, and local and systemic use of antibiotics[1],[7]; however, IOL removal decreases uncorrected visual acuity, leaving patients dissatisfied with the outcome, and likely leading to postoperative medical dissension. In most reports on the treatment of post-cataract endophthalmitis, the visual acuity of only half of the cases reached 20/40[8][9]. To date, there are few reports on the effect of vitrectomy on postoperative pseudophakic endophthalmitis without IOL removal. Therefore, the clinical features, causative organisms, and effects of vitrectomy and silicone oil tamponade without IOL removal in the treatment of APCE are reported here using a small case series.

SUBJECTS AND METHODS

Ethical Approval

The examination and treatment of the patients were approved by the Ethics Committee of the Tianjin Medical University General Hospital and informed consent forms were obtained from all patients.

Patients

This study involved a series of clinical characteristics and microbial factors in 10 eyes of 10 patients treated for APCE between January 2010 and December 2018 at Tianjin Medical University General Hospital. Post-cataract endophthalmitis is classified as APCE if it occurs within six weeks postoperatively, and chronic if it occurs after this period[3]. The diagnosis of APCE was the appearance of ocular pain, sudden vision decrease, conjunctival congestion and edema, corneal edema, hypopyon, and vitreous opacification after cataract surgery, regardless of whether the culture of intraocular fluid was ultimately positive[10][11]. Cases in which cataract surgery was combined with other eye surgeries were excluded. The posterior capsule had minor rupture during cataract surgery in 2 eyes, and was intact in 8 eyes. All patients received systemic antibiotics and vitrectomy combined with silicone oil tamponade, and the IOL was maintained in each eye.

The treatment indications for vitrectomy without IOL removal on APCE are as follows: 1) No abnormal changes in the implanted IOL, such as dissolution, reduced transparency, and deformation; 2) Patients with better corrected vision (>20/40) after cataract surgery before the occurrence of endophthalmitis; 3) Absence of zonular dialysis or severe rupture of the posterior capsule (>1/4 quadrant) during cataract surgery; 4) Patients without severe systemic diseases.

Surgical Procedures

All surgeries were performed under retrobulbar anesthesia (2.0% lidocaine) by the same surgeon (Yan H). An initial undiluted anterior chamber specimen was obtained for organism culture before irrigation/aspiration. The capsular bag was separated from the IOL with the use of viscoelastics. Then the anterior chamber and capsular bag were irrigated/aspirated completely and repeatedly. An initial undiluted vitreous specimen was also obtained for microbiological culture before vitrectomy. The posterior vitreous detachment from the optic disc was performed and infected vitreous was completely removed during vitrectomy. After vitrectomy, the anterior chamber and capsular bag were reirrigated/aspirated again if the anterior segment was not clear. Finally, the silicone oil was filled.

Postoperative Management and Follow-up

Routine topical cycloplegics (1.0% atropine sulfate) and topical corticosteroids (1.0% tobramycin dexamethasone) were administered 3 times per day for 7.0d after surgery. Systemic corticosteroids were administered orally with prednisolone at 30 mg once a day for 7.0d. Intravenous infusion of ofloxacin 100 mg twice a day for 7.0d and ofloxacin eye drops 3 times per day were then administered for 2.0wk. The routine follow-up was performed 1, 3, 5d, 1, 2, 4, 12wk, 6 and 12mo postoperatively.

Statistical Analysis

The Wilcoxon signed-rank test was used to assess the change in pre- and post-surgical IOP.

RESULTS

Demographics

The mean age of all patients was 71.4y (range, 63-84y; Table 1). Five patients had a history of diabetic mellitus. All patients had symptoms of acute ocular pain and a sudden decrease of vision after cataract surgery. All patients had hypopyon, edema cornea, hyperemic and edema conjunctiva. The mean time between cataract surgery and the onset of endophthalmitis was 2d with a range from 1 to 3d. The mean follow-up period was 25.5mo with a range from 16 to 53mo.

Table 1. Demographics and outcomes of vitrectomy for APCE in 10 patients.

Case No. Sex Age (y) Onset of APCE (d) VA
IOP (mm Hg)
Complications Silicone oil
Microorganisms cultures Follow-up (mo)
Preop. Postop. Preop. Postop. Intraop. Postop.
1 Male 74 3 LP 20/40 56 17 Exudates in AC Filling Removal Staphylococcus aureus 20
2 Male 67 1 HM 20/25 35 20 Exudates in AC, temporary IOP elevation Filling Removal Staphylococcus epidermidis 26
3 Female 84 3 NLP NLP 35 10 Exudates in AC Filling Unremoval Enterococcus 16
4 Male 72 1 LP 20/250 35 18 Exudates in AC Filling Removal Staphylococcus epidermidis 20
5 Male 68 2 LP 20/60 36 19 Exudates in AC Filling Removal Negative 30
6 Female 69 2 LP 20/100 35 18 Exudates in AC Filling Removal Staphylococcus epidermidis 53
7 Male 70 2 HM 20/200 35 17 Exudates in AC Filling Removal Staphylococcus epidermidis 19
8 Male 63 3 LP 20/60 32 9 Exudates in AC Filling Removal Negative 27
9 Male 71 2 LP 20/50 33 10 Exudates in AC Filling Removal Staphylococcus aureus 24
10 Female 76 3 LP 20/100 31 11 Exudates in AC Filling Removal Staphylococcus epidermidis 20

APCE: Acute-onset endophthalmitis after cataract surgery; VA: Visual acuity; IOP: Intraocular pressure; AC: Anterior chamber; LP: Light perception; HM: Hand moving; NLP: No light perception.

Causative Organisms

The microorganisms of the aqueous humor and vitreous were Staphylococcus epidermidis in 5 eyes (50%), Staphylococcus aureus in 2 eyes (20%), and Enterococcus in 1 eye (10%). Two eyes had negative cultures.

Visual Acuity

The pre-vitrectomy uncorrected visual acuity ranged from no light perception to hand motion and post-vitrectomy from no light perception to 20/25 at the last follow-up (Table 1). After vitrectomy, the visual acuity increased in 9 eyes (90%), and unchanged in 1 eye (10%).

Intraocular Pressure

The mean pre-vitrectomy IOP was 36.3 mm Hg, with a range from 31 to 56 mm Hg. The mean post-vitrectomy IOP was 14.9 mm Hg with a range from 9.0 to 20 mm Hg (P<0.05).

Other Postoperative Outcomes and Complications

After vitrectomy, the symptoms of ocular pain progressively disappeared in all eyes. Corneal transparency was recovered, and hypopyon was not visible. The IOL was transparent in all eyes. Retinas remained completely attached in all eyes (10/10, 100%) after vitrectomy. Silicone oil was removed in 9 eyes within 3.0-6.0mo postoperatively, and the retina remained attached in 9 eyes. The silicone oil was not removed in 1 eye that had no light perception because of serious retinal and vessel impairment. Figure 1 shows a case of APCE and final treatment result.

Figure 1. A case of acute-onset endophthalmitis after cataract surgery.

Figure 1

A: The dense vitreous opacity observed by ocular B-scan pre-vitrectomy; B: Hypopyon was observed pre-vitrectomy; C: Hypopyon completely disappeared 7d after vitrectomy.

DISCUSSION

APCE is a serious complication[12][13]. It is different from anterior segment toxic reaction syndrome (TASS) in clinical and laboratory examinations[13][14]. If patients are not treated in a timely manner, the prognosis is poor[12][13]. Post-vitrectomy retinal detachment and management of IOL are still controversial in the treatment of APCE[15][16]. Vitrectomy for endophthalmitis has several advantages for patients, such as removing the infected organism, toxins and the infected vitreous that can cause subsequent retinal detachment[17]. Previous studies have shown that vitrectomy with silicone oil tamponade is preferable for post-surgery endophthalmitis[18][21]. Complete and early clearance of purulence and toxins is the most critical procedure for endophthalmitis, which will promptly halt and reverse potentially devastating damage to the eyes. Complete and early vitrectomy was the initial treatment of choice and recommended by recent studies compared with the tap-and-inject process in the Endophthalmitis Vitrectomy Study (EVS), with 79% of eyes achieving ≥20/40 visual acuity in a recent study compared to 53% in the EVS, especially for those whose initial visual acuity was light perception only[18][21].

Various factors have been described that influence the prognosis of APCE, such as microorganism virulence and treatment[22][23]. In our study, the APCE was diagnosed within 2.0d after cataract surgery and was immediately treated by vitrectomy. The higher culture-positive rate was obtained included S. epidermidis in 5 eyes, Staphylococcus aureus in 2 eyes (20%), and Enterococcus in 1 eye. The visual acuity increased in 9 eyes (90%) postoperatively, and one-half of the patients had a final vision of 20/60 or better. No retinal detachment or ocular atrophy was observed during the follow-up period. These results indicate that vitrectomy combined with silicone oil tamponade without IOL removal is effective and timely for APCE in our case series.

Previous methods of treating APCE include vitrectomy combined with IOL removal and irrigation/aspiration of the anterior chamber[7]. The purpose of these manipulations was to remove the bacteria easily and completely from the anterior chamber and capsular bag. Hayashi et al[24] reported that in some cases with delayed-onset post-cataract endophthalmitis, and IOL removal was required to eliminate the bacteria that adhered to the tip of the IOL haptic. Dave et al[25] concluded that IOL explantation could be necessary in the management of delayed-onset post-cataract endophthalmitis, while explantation of IOL is not a standard recommendation in the management of APCE. In our study, complete irrigation/aspiration of the anterior chamber and capsular bag was conducted intraoperatively, and there was no remaining inflammation in the anterior segment at the final follow-up. Therefore, we got the same effects though the IOL was not removed.

In addition, treating APCE with IOL removal may have some shortcomings, including a decrease of uncorrected visual acuity, retinal detachment and requirement of a secondary IOL implantation[22]. In the present study, vitrectomy without IOL removal can also successfully eradicate the endophthalmitis, increase uncorrected visual acuity with a low rate of postoperative complications and reoperation, and reduce unnecessary medical dissension.

However, IOL removal or not in the treatment of APCE is still controversial, and we suggest that this management should be considered according to the different situations of different cases.

Acknowledgments

Foundation: Supported by The Youth Incubation Foundation of Tianjin Medical University General Hospital (No.ZYYFY2018013).

Conflicts of Interest: Guo HX, None; Xie RT, None; Wang Y, None; You CY, None; Liu YY, None; Meng XD, None; Yu JG, None; Yan H, None.

REFERENCES

  • 1.Simakurthy S, Tripathy K. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Endophthalmitis. [Google Scholar]
  • 2.Patwardhan A, Rao GP, Saha K, Craig EA. Incidence and outcomes evaluation of endophthalmitis management after phacoemulsification and 3-piece silicone intraocular lens implantation over 6 years in a single eye unit. J Cataract Refract Surg. 2006;32(6):1018–1021. doi: 10.1016/j.jcrs.2006.02.034. [DOI] [PubMed] [Google Scholar]
  • 3.Relhan N, Forster RK, Flynn HW., Jr Endophthalmitis: then and now. Am J Ophthalmol. 2018;187:xx–xxvii. doi: 10.1016/j.ajo.2017.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pershing S, Lum F, Hsu S, Kelly S, Chiang MF, Rich WL, 3rd, Parke DW., 2nd Endophthalmitis after cataract surgery in the United States: a report from the intelligent research in sight registry, 2013-2017. Ophthalmology. 2020;127(2):151–158. doi: 10.1016/j.ophtha.2019.08.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bainbridge JW, Teimory M, Tabandeh H, Kirwan JF, Dalton R, Reid F, Rostron CK. Intraocular lens implants and risk of endophthalmitis. Br J Ophthalmol. 1998;82(11):1312–1315. doi: 10.1136/bjo.82.11.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sun J, Guo Z, Li H, Yang B, Wu X. Acute infectious endophthalmitis after cataract surgery: epidemiological characteristics, risk factors and incidence trends, 2008-2019. Infect Drug Resist. 2021;14:1231–1238. doi: 10.2147/IDR.S304675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Das T, Dave VP, Dogra A, Joseph J, Sharma S, EMS working group Endophthalmitis management study. Report #1. Protocol. Indian J Ophthalmol. 2021;69(7):1936–1941. doi: 10.4103/ijo.IJO_199_21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kuhn F, Gini G. Ten years after… are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005;243(12):1197–1199. doi: 10.1007/s00417-005-0082-8. [DOI] [PubMed] [Google Scholar]
  • 9.Yannuzzi NA, Si N, Relhan N, Kuriyan AE, Albini TA, Berrocal AM, Davis JL, Smiddy WE, Townsend J, Miller D, Flynn HW., Jr Endophthalmitis after clear corneal cataract surgery: outcomes over two decades. Am J Ophthalmol. 2017;174:155–159. doi: 10.1016/j.ajo.2016.11.006. [DOI] [PubMed] [Google Scholar]
  • 10.Cunha AM, Iglésias MM, Rocha-Sousa A, Falcão-Reis F, Falcão M. Endophthalmitis following intravitreal injection, cataract surgery, and vitrectomy: clinical features and visual outcomes. J Ophthalmol. 2021;2021:9985821. doi: 10.1155/2021/9985821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kato JM, Tanaka T, de Oliveira LMS, de Oliveira MS, Rossi F, Goldbaum M, Pimentel SLG, de Almeida Junior JN, Yamamoto JH. Surveillance of post-cataract endophthalmitis at a tertiary referral center: a 10-year critical evaluation. Int J Retina Vitreous. 2021;7(1):14. doi: 10.1186/s40942-021-00280-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ma X, Xie L, Huang Y. Intraoperative cefuroxime irrigation prophylaxis for acute-onset endophthalmitis after phacoemulsification surgery. Infect Drug Resist. 2020;13:1455–1463. doi: 10.2147/IDR.S252674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sengillo JD, Chen Y, Perez Garcia D, Schwartz SG, Grzybowski A, Flynn HW., Jr Postoperative endophthalmitis and toxic anterior segment syndrome prophylaxis: 2020 update. Ann Transl Med. 2020;8(22):1548. doi: 10.21037/atm-2019-rcs-02. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hernandez-Bogantes E, Navas A, Naranjo A, Amescua G, Graue-Hernandez EO, Flynn HW, Jr, Ahmed I. Toxic anterior segment syndrome: a review. Surv Ophthalmol. 2019;64(4):463–476. doi: 10.1016/j.survophthal.2019.01.009. [DOI] [PubMed] [Google Scholar]
  • 15.Combey de Lambert A, Campolmi N, Cornut PL, Aptel F, Creuzot-Garcher C, Chiquet C, French Institutional Endophthalmitis Study Group Baseline factors predictive of visual prognosis in acute postoperative bacterial endophthalmitis in patients undergoing cataract surgery. JAMA Ophthalmol. 2013;131(9):1159–1166. doi: 10.1001/jamaophthalmol.2013.4242. [DOI] [PubMed] [Google Scholar]
  • 16.Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2021;32 Suppl 1:S1–S12. doi: 10.1097/ICU.0000000000000708. [DOI] [PubMed] [Google Scholar]
  • 17.Kannan NB, Sen S, Lalitha P, Mishra C, Rameshkumar G, Hariharan G, Siva Ganesa Karthikeyan R, Ramasamy K. Challenges in post-cataract surgery nocardia endophthalmitis: management strategies and clinical outcomes. Ocular Immunol Inflamm. 2020:1–6. doi: 10.1080/09273948.2020.1826536. [DOI] [PubMed] [Google Scholar]
  • 18.de Geus SJR, Hopman J, Brüggemann RJ, Klevering BJ, Crama N. Acute endophthalmitis after cataract surgery: clinical characteristics and the role of intracameral antibiotic prophylaxis. Ophthalmol Retina. 2021;5(6):503–510. doi: 10.1016/j.oret.2020.09.010. [DOI] [PubMed] [Google Scholar]
  • 19.Dib B, Morris RE, Oltmanns MH, Sapp MR, Glover JP, Kuhn F. Complete and early vitrectomy for endophthalmitis after cataract surgery: an alternative treatment paradigm. Clin Ophthalmol. 2020;14:1945–1954. doi: 10.2147/OPTH.S253228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Morris RE, Kuhn F. Complete and early vitrectomy for endophthalmitis. Eur J Ophthalmol. 2021;31(6):2794–2795. doi: 10.1177/11206721211021185. [DOI] [PubMed] [Google Scholar]
  • 21.Tabatabaei SA, Aminzade S, Ahmadraji A, Soleimani M, Sefidan BB, Kasaee A, Cheraqpour K. Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi-experimental study. BMC Ophthalmol. 2022;22(1):16. doi: 10.1186/s12886-022-02247-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shirodkar AR, Pathengay A, Flynn HW, Jr, Albini TA, Berrocal AM, Davis JL, Lalwani GA, Murray TG, Smiddy WE, Miller D. Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol. 2012;153(3):391–398.e2. doi: 10.1016/j.ajo.2011.08.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Patel SN, Storey PP, Levin H, Pancholy M, Obeid A, Wibbelsman TD, Kuley B, Ho AC, Hsu J, Garg SJ, Vander JF, Dunn JP. Endophthalmitis after cataract surgery: changes in management based on microbiologic cultures. Ophthalmol Retina. 2021;5(1):16–22. doi: 10.1016/j.oret.2020.06.028. [DOI] [PubMed] [Google Scholar]
  • 24.Hayashi Y, Eguchi H, Miyamoto T, Inoue M, Mitamura Y. A case of delayed-onset propionibacterium acnes endophthalmitis after cataract surgery with implantation of a preloaded intraocular lens. Case Rep Ophthalmol. 2012;3(3):291–297. doi: 10.1159/000342460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dave VP, Parmeshwarappa DC, Dogra A, Pappuru RR, Pathengay A, Joseph J, Das T. Clinical presentations and comparative outcomes of delayed-onset low-grade endophthalmitis managed with or without intraocular lens explantation. Clin Ophthalmol. 2020;14:551–555. doi: 10.2147/OPTH.S243496. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Ophthalmology are provided here courtesy of Press of International Journal of Ophthalmology

RESOURCES